Light­stone crew adds a $250M Fund II with plans to back biotech star­tups

When some of the life sci­ences crew at Ad­vanced Tech­nol­o­gy Ven­tures and Mor­gen­thaler Ven­tures band­ed to­geth­er to cre­ate Light­stone Ven­tures a lit­tle more than three years ago, they start­ed out with their first fund and a roll of the dice on Cataba­sis.

Since then, Cataba­sis has gone pub­lic $CATB, along with a few oth­er port­fo­lio com­pa­nies like Ra Phar­ma, and Light­stone is now tak­ing the wraps off of Fund II, which ups the ante con­sid­er­ably with a $250 mil­lion out­ing. The crew says they plan to stay fo­cused on biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER